StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Samsung Biologics Co.,Ltd.
KSE:207940.KS
Sector
Location
Market Cap
USD 55.01 B
Share Price
USD 783.00
Avg Daily Volume
79,266
Change (1 day)
6.24%
Change (1 year)
34.95%
Change (YTD)
22.05%
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 1.12 B
Samsung Biologics Co.,Ltd. Operating Cash Flow is USD 1.12 B for the year ending December 31, 2024, a -12.74% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 1.28 B, a 69.96% change year over year.
-
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 752.91 M, a 97.87% change year over year.
-
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 380.50 M, a 105.10% change year over year.
-
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 185.52 M, a 2,019.63% change year over year.
Competitors
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
BeOne Medicines Ltd.
USD 253.39
ONC
-2.30
-0.90%
bioMérieux S.A.
USD 142.27
BIM.PA
+1.98
1.41%
Baxter International Inc.
USD 29.70
BAX
-0.11
-0.37%
Regencell Bioscience Holdings Limited
USD 16.57
RGC
-0.83
-4.80%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.19
2196.HK
+0.03
1.58%
Globus Medical, Inc.
USD 57.80
GMED
+0.49
0.85%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.01
0.15%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.47
002653.SZ
+0.60
10.22%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.26
3347.HK
+0.12
1.91%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.74
300832.SZ
+0.01
0.07%
APT Medical Inc.
USD 41.66
688617.SS
+0.71
1.73%
Beijing Tiantan Biological Products Co., Ltd.
USD 2.75
600161.SS
+0.01
0.24%
TransMedics Group, Inc.
USD 124.78
TMDX
-1.63
-1.29%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.04
1.12%
Apeloa Pharmaceutical Co.,Ltd
USD 2.00
000739.SZ
+0.02
0.76%
Jubilant Pharmova Limited
USD 13.74
JUBLPHARMA.NS
+0.08
0.57%
QuidelOrtho Corporation
USD 31.55
QDEL
-0.02
-0.06%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.53
600420.SS
+0.02
1.30%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Siemens Healthineers AG
USD 55.98
SHL.DE
+0.43
0.78%
BeOne Medicines Ltd.
USD 253.39
ONC
-2.30
-0.90%
bioMérieux S.A.
USD 142.27
BIM.PA
+1.98
1.41%
Baxter International Inc.
USD 29.70
BAX
-0.11
-0.37%
Regencell Bioscience Holdings Limited
USD 16.57
RGC
-0.83
-4.80%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.19
2196.HK
+0.03
1.58%
Globus Medical, Inc.
USD 57.80
GMED
+0.49
0.85%
ConvaTec Group Plc
USD 3.58
CTEC.L
+0.01
0.15%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.47
002653.SZ
+0.60
10.22%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.26
3347.HK
+0.12
1.91%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.74
300832.SZ
+0.01
0.07%
APT Medical Inc.
USD 41.66
688617.SS
+0.71
1.73%
Beijing Tiantan Biological Products Co., Ltd.
USD 2.75
600161.SS
+0.01
0.24%
TransMedics Group, Inc.
USD 124.78
TMDX
-1.63
-1.29%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.04
1.12%
Apeloa Pharmaceutical Co.,Ltd
USD 2.00
000739.SZ
+0.02
0.76%
Jubilant Pharmova Limited
USD 13.74
JUBLPHARMA.NS
+0.08
0.57%
QuidelOrtho Corporation
USD 31.55
QDEL
-0.02
-0.06%
Shanghai Shyndec Pharmaceutical Co., Ltd.
USD 1.53
600420.SS
+0.02
1.30%